349 related articles for article (PubMed ID: 21855584)
1. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
[TBL] [Abstract][Full Text] [Related]
2. Interactions of formulation excipients with proteins in solution and in the dried state.
Ohtake S; Kita Y; Arakawa T
Adv Drug Deliv Rev; 2011 Oct; 63(13):1053-73. PubMed ID: 21756953
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
4. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
5. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
6. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
Dasnoy S; Le Bras V; Préat V; Lemoine D
Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
[TBL] [Abstract][Full Text] [Related]
7. Freeze drying formulation using microscale and design of experiment approaches: a case study using granulocyte colony-stimulating factor.
Grant Y; Matejtschuk P; Bird C; Wadhwa M; Dalby PA
Biotechnol Lett; 2012 Apr; 34(4):641-8. PubMed ID: 22187075
[TBL] [Abstract][Full Text] [Related]
8. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
9. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
10. Analytical methods and formulation factors to enhance protein stability in solution.
Jeong SH
Arch Pharm Res; 2012 Nov; 35(11):1871-86. PubMed ID: 23212628
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
[TBL] [Abstract][Full Text] [Related]
12. Protein stabilization by cyclodextrins in the liquid and dried state.
Serno T; Geidobler R; Winter G
Adv Drug Deliv Rev; 2011 Oct; 63(13):1086-106. PubMed ID: 21907254
[TBL] [Abstract][Full Text] [Related]
13. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.
Löbmann K; Laitinen R; Strachan C; Rades T; Grohganz H
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):882-8. PubMed ID: 23567485
[TBL] [Abstract][Full Text] [Related]
14. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
16. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
17. Design and utilization of the drug-excipient chemical compatibility automated system.
Thomas VH; Naath M
Int J Pharm; 2008 Jul; 359(1-2):150-7. PubMed ID: 18486368
[TBL] [Abstract][Full Text] [Related]
18. Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid)--a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release.
Agresti C; Tu Z; Ng C; Yang Y; Liang JF
Eur J Pharm Biopharm; 2008 Sep; 70(1):226-33. PubMed ID: 18514496
[TBL] [Abstract][Full Text] [Related]
19. Systematical approach of formulation and process development using roller compaction.
Teng Y; Qiu Z; Wen H
Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
[TBL] [Abstract][Full Text] [Related]
20. Impact Of Excipient Variability On Drug Product Processing And Performance.
Peng Soh JL; Liew CV; Sia Heng PW
Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
